尿液違禁品檢測試紙

                         廣州健侖生物科技有限公司                      

Plasmodium proliferate in erythrocytes, rupture of erythrocytes, malaria pigment and metabolites into the blood, causing chills, fever and sweating (one cycle); release of some merozoites into other erythrocyte proliferation, causing a new round of red cell lysis And symptoms. Another part of merozoites by the mononuclear - phagocytic system eliminated.
Vivax and oval-shaped malaria attack naive RBCs
Malaria on the 3rd attack the aging RBC
It is easy to cause cerebral edema, coma, kidney damage, blood stasis and so on.RBCs of all ages can cause RBC (erythrocytes that form echinococcosis with erythrocytes, easy to accumulate and adhere to blood vessel wall, cause vascular blockage, cause ischemic degeneration and necrosis of local tissue cells, Pulmonary edema and heart failure, etc ..) five: pathological changes: vivax malaria and malaria erythrocytic stage in the peripheral blood, the main lesion in the mononuclear - macrophage system;
The erythrocytic stage of falciparum malaria occurs in the visceral microvessels, the major lesion being in the viscera, resulting in visceral damage.
Spleen: mild acute enlargement; a large number of RBC visible in the spleen, its malaria parasite and malaria pigment. Chronic phase was significantly enlarged, cirrhosis; section color gray; medullary reticular tissue fibrosis, blood vessels and sinus wall thickening, medulla mostly mononuclear cells.
Liver: mild swelling. Hepatic cell degeneration, to lobular central area significantly; kupffer cell proliferation, containing Plasmodium and malaria pigment.
Brain: Cerebral edema and congestion in patients with falciparum malaria; diffuse bleeding in white matter. Microvascular congestion in the brain, a large number of plasmodium within the lumen and malaria pigment. Agglutination of red blood cells, microvascular obstruction, focal necrosis of brain tissue, annular hemorrhage.

獨立包裝：BZO-BAR-COC--THC -MET--OPI-OXY-MDMA-PCP- AMP-XTC-MTD 或聯檢

MOB： 楊   ： 

尿液違禁品檢測試紙

     以下可以自由COMBO多聯檢測卡

添加掃一掃二維碼：

【公司名稱】 廣州健侖生物科技有限公司

【市場部】       楊永漢
【】 
【騰訊 】
【公司地址】 廣州市清華科技園健新基地番禺石樓鎮健啟路63號二期2幢101-103室

企業文化

Vaccine levels of protective antibodies obtained from studies in rabbits and monkeys as experimental animals were used to predict the level of immune response in humans. When the animal model of inhalation anthrax has a 70% protection rate, it is considered a reasonable level of protection and may also be so in humans.
Rabbits were used to evaluate the effect of BioThrax for post-exposure injection combined with antibiotic therapy to increase survival. As a result, the survival rate of rabbits treated with both antibiotics and BioThrax was between 70-100%. The specific survival rate was related to the dosage and route of administration of the vaccine. Survival rates of rabbits treated with antibiotics were only 44% and 23%, respectively.
Adverse reactions to BioThrax are mainly local adverse reactions at the injection site, such as injection site pain, tenderness, pain, swelling, and limited arm motility during injection. The most common systemic side effects seen are muscle aches, headaches, and fatigue. Researchers have found a new gene that is highly resistant to the ultimate antibiotic in samples collected from humans and pigs in various parts of China, including infectious bacterial specimens.
Reuters reported on November 18 that scientists found the discovery "troubling" and called for an urgent limit on the use of polymyxins. Polymyxin is an antibiotic that includes medicinal colistin and is widely used in animal husbandry. Laura Picode, a professor of microbiology at the University of Birmingham in the United Kingdom, said: "All polymyxins must be used as quickly as possible and all unnecessary use is stopped."
Liu Jianhua, a research team at South China Agricultural University in China, published their research results in the British journal Lancet Infectious Bacteria. They found the gene called mcr-1 on the plasmid. Plasmids are removable DNA elements that are easily replicated and transferred between different bacteria. They say this shows "the worrying potential" that the gene has the ability to spread and mutate between bacterial populations.
The team has found evidence of the transfer of the mcr-1 gene from bacteria to bacteria, such as between E. coli, which causes infections of the urethra and other types, and Klebsiella pneumoniae, which causes pneumonia and other infections. This shows that "the development from multi-drug resistance to pan-drug resistance is inevitable." "Although currently limited to China, mcr-1 is likely to be the same as other resistance genes ... and spread to the world quickly."
The growing spread of the mcr-1 resistance gene was discovered, reminiscent of news that another 2010 so-called "superbug" gene NDM-1 was discovered. That gene appeared in India and soon spread to the world.
Pidok et al say that there is now a need to establish a global mcr-1 drug resistance gene surveillance system in an effort to stop the spread of polymyxin-resistant bacteria.
China is one of the largest producers and consumers of colistin for agriculture and veterinary in the world.